Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 725.28

+3.0%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Biotech Jim

To: Felix B who wrote (2379)	4/7/2018 8:05:22 PM
From: Miljenko Zuanic	1 Recommendation of 3559

They need break true with additional drug (like Eylea), but not splitting US-shares 50% with someone else! For instance Dupi is selling fine (relative fine) in US but POORLY in EU? That is a problem, return on R&D investment, or do not do R&D at all. DO LICENSE, like everybody else!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next